Key Development On August 28, 2026, the U.S. FDA approved an expanded indication for Eli Lilly’s Mounjaro® (tirzepatide) to reduce... Read more
Category: Uncategorized
GENENTECH–DUALITYBIO: THE ADC RACE ENTERS THE NEXT-GENERATION PAYLOAD ERA
Key Development Genentech, a member of the Roche Group, has entered a global collaboration and licensing agreement with DualityBio to... Read more
FDA APPROVAL OF MIMRYLO ESTABLISHES HEPcidin MIMETICS AS A NEW THERAPEUTIC APPROACH IN POLYCYTHEMIA VERA
Key Development On August 28, 2026, the U.S. Food and Drug Administration approved MIMRYLO™ (rusfertide) for the treatment of erythrocytosis... Read more
ORAL WEGOVY MOVES INTO CHINA: THE GLP-1 RACE IS SHIFTING FROM EFFICACY TO MARKET ACCESS
Key Development On August 27, 2026, Chinese regulators accepted Novo Nordisk’s marketing application for the oral version of Wegovy (semaglutide).... Read more
Why Does a Business Need an Emergency Response Team?
A small fire in the warehouse. An employee collapsing in cardiac arrest at their desk. A chemical spill on the... Read more
Lifestyle Change: The Real Key to Effective Diabetes Control
No complex medication required — lifestyle change alone has been shown to be one of the most effective interventions available... Read more
Healthcare Alliance Vietnam & VietnamWellcare™ Officially Sign Strategic Partnership
On November 11, 2025, 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐀𝐥𝐥𝐢𝐚𝐧𝐜𝐞 𝐕𝐢𝐞𝐭𝐧𝐚𝐦 and 𝐕𝐢𝐞𝐭𝐧𝐚𝐦𝐖𝐞𝐥𝐥𝐜𝐚𝐫𝐞™ marked a major strategic milestone by signing a comprehensive partnership agreement.... Read more
Navigating the hyper-velocity era: How leaders resolve the AI productivity bottleneck
The abundance paradox and the feedback bottleneck The widespread integration of generative models and automated agentic tools has compressed corporate... Read more
Mitigating toxic executive hires through structured cultural alignment screening
In highly competitive executive search markets, talent acquisition panels frequently prioritize candidates who demonstrate exceptional functional capabilities and aggressive career... Read more









